Machine Learning Characterization of COPD Subtypes
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
- Novartis
- National Heart, Lung, and Blood Institute (R01 HL124233, U01 HL089856, U01 HL089897)
- COPD Foundation
- Novartis Pharmaceuticals Corporation
- Janssen Pharmaceutica
- Boehringer Ingelheim
This publication has 45 references indexed in Scilit:
- Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigationRespiratory Research, 2010
- Genetic Epidemiology of COPD (COPDGene) Study DesignCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Clinical COPD phenotypes: a novel approach using principal component and cluster analysesEuropean Respiratory Journal, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- The overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax, 2009
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- THE EMPHYSEMATOUS AND BRONCHIAL TYPES OF CHRONIC AIRWAYS OBSTRUCTIONThe Lancet, 1966
- Terminology, Definitions, and Classification of Chronic Pulmonary Emphysema and Related Conditions: A REPORT OF THE CONCLUSIONS OF A CIBA GUEST SYMPOSIUMThorax, 1959